Checking the Checkpoint Inhibitors: A Case of Autoimmune Diabetes After PD-1 Inhibition in a Patient with HIV

Immune checkpoint inhibitor–associated diabetes mellitus (ICI-DM) is a known immune-related adverse event (irAE) following treatment with programmed cell death protein 1 (PD-1), with a reported 0.9% incidence. We hereby present the first case, to our knowledge, of ICI-DM following ICI use in a human...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Michael S, Pietropaolo, Massimo, Vasudevan, Madhuri M, Marcelli, Marco, Nguyen, Ha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660136/
https://www.ncbi.nlm.nih.gov/pubmed/33225197
http://dx.doi.org/10.1210/jendso/bvaa150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660136/
https://www.ncbi.nlm.nih.gov/pubmed/33225197
http://dx.doi.org/10.1210/jendso/bvaa150

Ejemplares similares